Doctors info

Professional Overview

Dr. Vinayak Munirathnam is a Senior Consultant in Medical Oncology at Sri Shankara Cancer Hospital & Research Centre, Bangalore, with over 15 years of experience.

He holds MBBS, MD (Pediatrics), DM (Medical Oncology), is ESMO certified, and has a fellowship from Japan in Transplant and Solid Oncology. His expertise includes hematological malignancies, bone marrow transplantation, pediatric and adult solid tumors, immunotherapy, and precision oncology. He has held key roles at top hospitals and actively leads and collaborates on multiple national and international clinical trials. His research includes peer-reviewed publications on brain tumors, lymphomas, and cancer treatment outcomes

Research Publications

1. Ogilvie Syndrome in a Refractory Germ Cell Tumor Treated with Vinblastine, Ifosfamide and Cisplatin Regimen

Authors: Varayathu H, Shah MS, Sarathy V, Thomas BE, Munirathnam V, Shivalingappa SS, Naik R

Journal: Case Reports in Oncology

Published: 2021 Sep 28

Additional Details: 13(3):1171-5

2. Frequency and Prognosis of Epidermal Growth Factor Receptor Variant III Mutations in Glioblastoma Multiforme among Indian Patients: A Single-Institution Study

Authors: Jose WM, Munirathnam V, Narendranath V, Philip A, Keechilat P

Journal: South Asian Journal of Cancer

Published: 2020 Jul

Additional Details: 9(03):126-9

3. MicroRNA-mediated resistance mechanisms in NAT-treated HER2-positive breast cancer (BC): A single centre retrospective analysis from matched primary and residual tumours

Authors: Mathranda SA, Kumar P, Kumar R, Srihari S, Diwaker R, Munirathnam V, Simha V, Anantharamu S, RN S, PS H, Veeraiyan D

4. NRF2 signaling pathway in chemo/radio/immuno-therapy resistance of lung cancer: looking beyond the tip of the iceberg

Authors: Ramisetti SV, Patra T, Munirathnam V, Sainath JV, Veeraiyan D, Namani A

Journal: Archivos de Bronconeumología

Published: 2024 Oct 1

Additional Details: 60:S59-66

5. Immune infiltration in TP53 missense mutant contributes to poor prognosis in hepatocellular carcinoma, unlike CTNNB1 mutations

Authors: Veeraiyan D, Kurpad V, Munirathnam V, V C, Asthana S, Namani A, Patra T

Journal: Malignancy Spectrum

Published: 2025 Sep

Additional Details: 2(3):117-27

Languages Spoken

Kannada English Hindi Telugu

Dr. Vinayak Munirathnam